Search

Your search keyword '"Dumlupinar, Cansu"' showing total 11 results
Start Over Author "Dumlupinar, Cansu"
11 results on '"Dumlupinar, Cansu"'

4. Supplementary Table S4 from Detection of Recurrence through microRNA-371a-3p Serum Levels in a Follow-up of Stage I Testicular Germ Cell Tumors in the DRKS-00019223 Study

Author

Belge, Gazanfer, primary, Dumlupinar, Cansu, primary, Nestler, Tim, primary, Klemke, Markus, primary, Törzsök, Peter, primary, Trenti, Emanuela, primary, Pichler, Renate, primary, Loidl, Wolfgang, primary, Che, Yue, primary, Hiester, Andreas, primary, Matthies, Cord, primary, Pichler, Martin, primary, Paffenholz, Pia, primary, Kluth, Luis, primary, Wenzel, Mike, primary, Sommer, Jörg, primary, Heinzelbecker, Julia, primary, Schriefer, Philipp, primary, Winter, Alexander, primary, Zengerling, Friedemann, primary, Kramer, Mario Wolfgang, primary, Lengert, Marie, primary, Frey, Jana, primary, Heidenreich, Axel, primary, Wülfing, Christian, primary, Radtke, Arlo, primary, and Dieckmann, Klaus-Peter, primary

Published
2024
Full Text
View/download PDF

5. Supplementary Figure S1 from Detection of Recurrence through microRNA-371a-3p Serum Levels in a Follow-up of Stage I Testicular Germ Cell Tumors in the DRKS-00019223 Study

Author

Belge, Gazanfer, primary, Dumlupinar, Cansu, primary, Nestler, Tim, primary, Klemke, Markus, primary, Törzsök, Peter, primary, Trenti, Emanuela, primary, Pichler, Renate, primary, Loidl, Wolfgang, primary, Che, Yue, primary, Hiester, Andreas, primary, Matthies, Cord, primary, Pichler, Martin, primary, Paffenholz, Pia, primary, Kluth, Luis, primary, Wenzel, Mike, primary, Sommer, Jörg, primary, Heinzelbecker, Julia, primary, Schriefer, Philipp, primary, Winter, Alexander, primary, Zengerling, Friedemann, primary, Kramer, Mario Wolfgang, primary, Lengert, Marie, primary, Frey, Jana, primary, Heidenreich, Axel, primary, Wülfing, Christian, primary, Radtke, Arlo, primary, and Dieckmann, Klaus-Peter, primary

Published
2024
Full Text
View/download PDF

6. Data from Detection of Recurrence through microRNA-371a-3p Serum Levels in a Follow-up of Stage I Testicular Germ Cell Tumors in the DRKS-00019223 Study

Author

Belge, Gazanfer, primary, Dumlupinar, Cansu, primary, Nestler, Tim, primary, Klemke, Markus, primary, Törzsök, Peter, primary, Trenti, Emanuela, primary, Pichler, Renate, primary, Loidl, Wolfgang, primary, Che, Yue, primary, Hiester, Andreas, primary, Matthies, Cord, primary, Pichler, Martin, primary, Paffenholz, Pia, primary, Kluth, Luis, primary, Wenzel, Mike, primary, Sommer, Jörg, primary, Heinzelbecker, Julia, primary, Schriefer, Philipp, primary, Winter, Alexander, primary, Zengerling, Friedemann, primary, Kramer, Mario Wolfgang, primary, Lengert, Marie, primary, Frey, Jana, primary, Heidenreich, Axel, primary, Wülfing, Christian, primary, Radtke, Arlo, primary, and Dieckmann, Klaus-Peter, primary

Published
2024
Full Text
View/download PDF

7. Detection of recurrence through microRNA-371a-3p serum levels in a follow-up of stage I testicular germ cell tumors in the DRKS-00019223 study

Author

Belge, Gazanfer, primary, Dumlupinar, Cansu, additional, Nestler, Tim, additional, Klemke, Markus, additional, Törzsök, Peter, additional, Trenti, Emanuela, additional, Pichler, Renate, additional, Loidl, Wolfgang, additional, Che, Yue, additional, Hiester, Andreas, additional, Matthies, Cord, additional, Pichler, Martin, additional, Paffenholz, Pia, additional, Kluth, Luis, additional, Wenzel, Mike, additional, Sommer, Jörg, additional, Heinzelbecker, Julia, additional, Schriefer, Philipp, additional, Winter, Alexander, additional, Zengerling, Friedemann, additional, Kramer, Mario Wolfgang., additional, Lengert, Marie, additional, Frey, Jana, additional, Heidenreich, Axel, additional, Wülfing, Christian, additional, Radtke, Arlo, additional, and Dieckmann, Klaus-Peter, additional

Published
2023
Full Text
View/download PDF

9. Associations of serum levels of microRNA-371a-3p (M371) with risk factors for progression in nonseminomatous testicular germ cell tumours clinical stage 1

Author

Dieckmann, Klaus-Peter, primary, Dumlupinar, Cansu, additional, Radtke, Arlo, additional, Matthies, Cord, additional, Pichler, Renate, additional, Paffenholz, Pia, additional, Sommer, Jörg, additional, Winter, Alexander, additional, Zengerling, Friedemann, additional, Hennig, Finja, additional, Wülfing, Christian, additional, and Belge, Gazanfer, additional

Published
2021
Full Text
View/download PDF

11. Detection of Recurrence through microRNA-371a-3p Serum Levels in a Follow-up of Stage I Testicular Germ Cell Tumors in the DRKS-00019223 Study.

Author

Belge G, Dumlupinar C, Nestler T, Klemke M, Törzsök P, Trenti E, Pichler R, Loidl W, Che Y, Hiester A, Matthies C, Pichler M, Paffenholz P, Kluth L, Wenzel M, Sommer J, Heinzelbecker J, Schriefer P, Winter A, Zengerling F, Kramer MW, Lengert M, Frey J, Heidenreich A, Wülfing C, Radtke A, and Dieckmann KP

Subjects
Male, Humans, Follow-Up Studies, Biomarkers, Tumor genetics, Neoplasm Recurrence, Local diagnosis, Neoplasm Recurrence, Local genetics, Recurrence, MicroRNAs genetics, Testicular Neoplasms diagnosis, Testicular Neoplasms genetics, Testicular Neoplasms pathology, Neoplasms, Germ Cell and Embryonal diagnosis, Neoplasms, Germ Cell and Embryonal genetics
Abstract

Purpose: Surveillance of clinical stage I (CSI) testicular germ cell tumors (GCT) is hampered by low sensitivity and specificity of current biomarkers for detecting relapses. This study evaluated if serum levels of microRNA371a-3p (M371 test) can: (i) Accurately detect relapses, (ii) detect relapses earlier than conventional technology, and (iii) if elevated postoperative M371 levels may predict relapse., Experimental Design: In a multicentric setting, 258 patients with testicular CSI GCT were prospectively followed by surveillance for a median time of 18 months with serial measurements of serum M371 levels, in addition to standard diagnostic techniques. Diagnostic characteristics of M371 for detecting relapses were calculated using ROC curve analysis., Results: Thirty-nine patients recurred (15.1%), all with elevated M371 levels; eight without relapse had elevations, too. The test revealed the following characteristics: area under the ROC curve of 0.993, sensitivity 100%, specificity 96.3%, positive predictive value 83%, negative predictive value 100%. Earlier relapse detection with the test was found in 28%, with non-significant median time gain to diagnosis. Postoperative M371 levels did not predict future relapse., Conclusions: The sensitivity and specificity of the M371 test for detecting relapses in CSI GCTs are much superior to those of conventional diagnostics. However, post-orchiectomy M371 levels are not predictive of relapse, and there is no significant earlier relapse detection with the test. In all, there is clear evidence for the utility of the M371 test for relapse detection suggesting it may soon be ready for implementation into routine follow-up schedules for patients with testicular GCT., (©2023 The Authors; Published by the American Association for Cancer Research.)

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results